Many copay programs have an INC offer component but many of our clients don’t differentiate the two types of patients typically grouped within their program and this can cost them. INC can be two types of patients: Insured Not Covered 1 (INC1) – have commercial coverage but are also in

All brands should strive to get the most from their copay program. We have been helping brands optimize their copay programs since copay began in the industry. There are many places where you can get tripped up when it comes to developing your program. The issues that we have found

There is a major flaw in the way companies evaluate their copay incentive programs and it can cause a brand to overspend. When it comes time to renew a program, a brand may choose to increase their patient incentive offer intending to increase sales (lower the face value from $20

As you likely know, a “specialty” medication is a drug that treats rare and/or complex diseases and disorders. There are many complexities and challenges associated with getting patients on a specialty medication and keeping them on therapy. Typically, a patient will need a prior authorization, step therapy or some other

There are many things you must consider when planning your copay program, but one of the most important things is a step that is skipped by the majority of brand planners. To plan programs and project program cost you need to know what your patient’s OOP cost would be before